open access (technical)
.....
CCC is the second most common EOC subtype after HGSC. More than 50% of
inactivating mutations in the AT-rich interactive domain 1A gene (
ARID1A), almost 40% of activating mutations in the gene encoding the catalytic subunit of phosphatidylinositol 3-kinase (
PIK3CA), and
microsatellite instability characterize the genetic alterations in CCC
[1].
A recent large-cohort study found a pattern in CCC of resistance to
standard platinum-based chemotherapy, which offers poor prognosis for
patients diagnosed in advanced clinical stages (i.e., International
Federation of Gynecology and Obstetrics stages III and IV)
[2].
The ratio of CCC among EOC in Japan is reported to be higher than that
in Western countries (15–25% and 5–12%, respectively); ethnic or
geographical differences in its incidence have also been noticed [3]......
Results
ANXA4 was highly expressed in CCC specimens
Images corresponding to each representative IHC score and a summary of the results are shown in
Figure 1A and B.
All 52 CCC specimens demonstrated significant staining for ANXA4 (IHC score 5 or 6) without exception, with P<0.05 against all other types of ovarian carcinomas and LMP tumors (Figure 1B).
In carcinoma cases, although
few cases were available for IHC,
all four
mucinous carcinomas and two of six endometrioid carcinomas showed high
levels (IHC score 4 or greater) of ANXA4 expression. Conversely, all
three poorly or undifferentiated carcinomas and 13 of 14 SC expressed no
detectable ANXA4. Only two mucinous adenomas were examined, but both of
them showed an IHC score 6 expression of ANXA4, presenting a similarity
to their malignant counterpart.
Only one case of normal premenopausal
ovary was available for IHC, but no ovarian components, including
surface epithelium, follicles, and stromal tissues, were reactive for
ANXA4.....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.